SMI
11 942,05
|
24,46
|
0,21%
|
Analysen zu SMI-Werten
23.06.23 | Givaudan Hold | Deutsche Bank AG | |
23.06.23 | Givaudan Sell | UBS AG | |
22.06.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
22.06.23 | Roche Sell | Deutsche Bank AG | |
22.06.23 | UBS Overweight | JP Morgan Chase & Co. | |
22.06.23 | Richemont Overweight | JP Morgan Chase & Co. | |
20.06.23 | Roche Sell | Deutsche Bank AG | |
16.06.23 | Givaudan Sell | Goldman Sachs Group Inc. | |
15.06.23 | Novartis Underweight | Barclays Capital | |
15.06.23 | Roche Neutral | UBS AG | |
15.06.23 | Novartis Neutral | UBS AG | |
14.06.23 | Nestlé Underperform | RBC Capital Markets | |
14.06.23 | Nestlé Buy | UBS AG | |
13.06.23 | Novartis Buy | Deutsche Bank AG | |
12.06.23 | UBS Sector Perform | RBC Capital Markets | |
12.06.23 | UBS Buy | Goldman Sachs Group Inc. | |
12.06.23 | Givaudan Hold | Deutsche Bank AG | |
12.06.23 | Nestlé Buy | Deutsche Bank AG | |
12.06.23 | ABB Neutral | JP Morgan Chase & Co. | |
09.06.23 | Roche Underweight | JP Morgan Chase & Co. | |
09.06.23 | Nestlé Neutral | Credit Suisse Group | |
09.06.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
09.06.23 | UBS Buy | Goldman Sachs Group Inc. | |
09.06.23 | UBS Overweight | JP Morgan Chase & Co. | |
09.06.23 | Holcim Neutral | JP Morgan Chase & Co. | |
09.06.23 | Novartis Buy | Jefferies & Company Inc. | |
09.06.23 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.06.23 | Roche Hold | Jefferies & Company Inc. | |
07.06.23 | UBS Overweight | JP Morgan Chase & Co. | |
07.06.23 | Nestlé Market-Perform | Bernstein Research | |
07.06.23 | ABB Outperform | Bernstein Research | |
07.06.23 | Givaudan Sell | Goldman Sachs Group Inc. | |
06.06.23 | Novartis Buy | Deutsche Bank AG | |
06.06.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
05.06.23 | Novartis Neutral | UBS AG | |
05.06.23 | Roche Equal Weight | Barclays Capital | |
05.06.23 | Novartis Buy | Deutsche Bank AG | |
05.06.23 | Novartis Underweight | Barclays Capital | |
05.06.23 | Roche Underweight | JP Morgan Chase & Co. | |
02.06.23 | Novartis Buy | Jefferies & Company Inc. |